350 related articles for article (PubMed ID: 11395757)
1. Alzheimer's disease. Molecular consequences of presenilin-1 mutation.
Gandy S; Naslund J; Nordstedt C
Nature; 2001 Jun; 411(6838):654-6. PubMed ID: 11395757
[TBL] [Abstract][Full Text] [Related]
2. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein.
De Strooper B; Saftig P; Craessaerts K; Vanderstichele H; Guhde G; Annaert W; Von Figura K; Van Leuven F
Nature; 1998 Jan; 391(6665):387-90. PubMed ID: 9450754
[TBL] [Abstract][Full Text] [Related]
5. [Beta-amyloid protein: recent progress in basic research and therapeutic approaches].
Iwatsubo T
Rinsho Shinkeigaku; 2001 Dec; 41(12):1198-200. PubMed ID: 12235837
[TBL] [Abstract][Full Text] [Related]
6. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
Bentahir M; Nyabi O; Verhamme J; Tolia A; Horré K; Wiltfang J; Esselmann H; De Strooper B
J Neurochem; 2006 Feb; 96(3):732-42. PubMed ID: 16405513
[TBL] [Abstract][Full Text] [Related]
7. FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex.
Xia W; Ostaszewski BL; Kimberly WT; Rahmati T; Moore CL; Wolfe MS; Selkoe DJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):673-81. PubMed ID: 11114265
[TBL] [Abstract][Full Text] [Related]
8. Presenilin, Notch, and the genesis and treatment of Alzheimer's disease.
Selkoe DJ
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11039-41. PubMed ID: 11572965
[TBL] [Abstract][Full Text] [Related]
9. Presenilin-1 mutations in Alzheimer's disease.
Russo C; Schettini G; Saido TC; Hulette C; Lippa C; Lannfelt L; Ghetti B; Gambetti P; Tabaton M; Teller JK
Nature; 2000 Jun; 405(6786):531-2. PubMed ID: 10850703
[No Abstract] [Full Text] [Related]
10. gamma-Secretase can cleave amyloid precursor protein fragments independent of alpha- and beta-secretase pre-cutting.
Kume H; Sekijima Y; Maruyama K; Kametani F
Int J Mol Med; 2003 Jul; 12(1):57-60. PubMed ID: 12792809
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N
Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948
[TBL] [Abstract][Full Text] [Related]
12. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein.
Citron M; Eckman CB; Diehl TS; Corcoran C; Ostaszewski BL; Xia W; Levesque G; St George Hyslop P; Younkin SG; Selkoe DJ
Neurobiol Dis; 1998 Aug; 5(2):107-16. PubMed ID: 9746908
[TBL] [Abstract][Full Text] [Related]
13. Proprotein convertase activity contributes to the processing of the Alzheimer's beta-amyloid precursor protein in human cells: evidence for a role of the prohormone convertase PC7 in the constitutive alpha-secretase pathway.
Lopez-Perez E; Seidah NG; Checler F
J Neurochem; 1999 Nov; 73(5):2056-62. PubMed ID: 10537065
[TBL] [Abstract][Full Text] [Related]
14. Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane.
Kaether C; Lammich S; Edbauer D; Ertl M; Rietdorf J; Capell A; Steiner H; Haass C
J Cell Biol; 2002 Aug; 158(3):551-61. PubMed ID: 12147673
[TBL] [Abstract][Full Text] [Related]
15. Presenilin 1 binds to amyloid precursor protein directly.
Waragai M; Imafuku I; Takeuchi S; Kanazawa I; Oyama F; Udagawa Y; Kawabata M; Okazawa H
Biochem Biophys Res Commun; 1997 Oct; 239(2):480-2. PubMed ID: 9344855
[TBL] [Abstract][Full Text] [Related]
16. Generation of amyloid beta protein from a presenilin-1 and betaAPP complex.
Shizuka-Ikeda M; Matsubara E; Ikeda M; Kanai M; Tomidokoro Y; Ikeda Y; Watanabe M; Kawarabayashi T; Harigaya Y; Okamoto K; Maruyama K; Castaño EM; St George-Hyslop P; Shoji M
Biochem Biophys Res Commun; 2002 Mar; 292(2):571-8. PubMed ID: 11906199
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease. A technical KO of amyloid-beta peptide.
Haass C; Selkoe DJ
Nature; 1998 Jan; 391(6665):339-40. PubMed ID: 9450743
[No Abstract] [Full Text] [Related]
18. [beta-amyloid cascade: current status and future directions].
Iwatsubo T
Rinsho Shinkeigaku; 2000 Dec; 40(12):1228-30. PubMed ID: 11464463
[TBL] [Abstract][Full Text] [Related]
19. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
[TBL] [Abstract][Full Text] [Related]
20. [The mechanism of A beta production and its inhibition as a therapeutic strategy for the prevention of Alzheimer's disease].
Iwatsubo T
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):30P-33P. PubMed ID: 12491772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
